Nebulizer Market: Provides Life Support to Respiratory Patient

Focus on technically sophisticated consistent device for the conversion of liquid drug to mist or aerosol is a next big thing in medical device industries who are involved in making nebulizers. Nebulizer is one of the most promising products in the market that converts liquid medication into mist and thereby provides life support to many of the respiratory patient. Nebulizer is widely utilized for the treatment of COPD (chronic obstructive pulmonary disease), cystic fibrosis (CFTR) and asthma. Industry experts believe that nebulizer is expected to revolutionize the respiratory treatment market making the device an integral part of critically ill respiratory patient.

For the first time nebulizer was used by French inventor named Dr. Sales-Girons in the year 1858 that acts as an air initiator. Over the past few decades the technologies that are utilized in nebulizer has improved significantly owing to rising prevalence of respiratory disorders coupled with increasing geriatric population worldwide. In recent times automated nebulizer is available that is powered by electric current and rechargeable batteries. However, drug lose at the time of delivery is a crucial factor that would restrict nebulizers demand to some extent in the global market.

Various nebulizers are utilized for the delivery of liquid drug as a mist into a patient. That includes pneumatic nebulizer, ultrasonic nebulizer and mesh nebulizer. Breath actuated pneumatic nebulizer is accounted as a potential product type in the global market that holds the largest market share due to easy to handle and provides efficient drug delivery. As per research conducted by Transparency Market Research, the total global nebulizers market is expected to reach an estimated value of USD 937.7 million by 2019. This indicates the huge potential and scope for the development of better and advanced nebulizer products by manufacturers. Transparency Market Research, a leading U.S.-based Market Research firm, analyzes the market for nebulizers and predicts it to grow at a compounded annual growth rate of 6.5% for the period 2013 to 2019.

It was also observed that companies who are involved in manufacturing nebulizers provide more preference to Asian countries owing to untapped nature of the market. In addition, large patient pool suffering from various chronic diseases such as asthma, COPD and cystic fibrosis in these economies.

Thus, it can be securely concluded that the future of the nebulizer industry holds immense potential for market growth due to the introduction of technology utilized in mesh nebulizers. Moreover, manufacturers invest a huge amount in research and development activities to bring revolutionary persistent product in the market, which will further augment the uptake of these devices.

Major vendors involved in the manufacturing process of nebulizers and accounted for the global market share of nebulizers include Philips Healthcare, Omron Healthcare, GF Health Products, Inc. and PARI Respiratory, Equipment Inc.

Preeti Wani
Hi I am Preeti Bagade, Research Analyst working with Europlat.Org. I have completed my MBA with Marketing as my specialization from University of Pune. The current work profile includes conducting market research (secondary and primary) and consulting projects for various sectors of Healthcare (pharmaceutical and medical devices) industry.